ReNeuron Group

RENE:LNLondon Stock Exchange (AIM)

Overview

Company Profile

We are a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.

Classification

SectorHealthcare
ExchangeLondon Stock Exchange (AIM)
BoardAIM